{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:29:50Z","timestamp":1793665790276,"version":"4.5.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["painjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.pain.2013.08.011","type":"journal-article","created":{"date-parts":[[2013,8,17]],"date-time":"2013-08-17T22:00:38Z","timestamp":1376776838000},"page":"2769-2774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Discrepancies between registered and published primary outcome specifications in analgesic trials: ACTTION systematic review and recommendations"],"prefix":"10.1097","volume":"154","author":[{"given":"Shannon M.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony T.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McKeown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Rowbotham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie B.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Coplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Gilron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon H.","family":"Hertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel P.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison H.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elektra J.","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob A.","family":"Rappaport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis C.","family":"Turk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Dworkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R5-28-20210112","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(08)61060-0","article-title":"Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet.","volume":"372","author":"Al-Marzouki","year":"2008","journal-title":"Lancet"},{"key":"R10-28-20210112","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jama.290.7.921","article-title":"Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?","volume":"290","author":"Als-Nielsen","year":"2003","journal-title":"JAMA"},{"key":"R15-28-20210112","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/pst.310","article-title":"The impact of missing data and how it is handled on the rate of false-positive results in drug development.","volume":"7","author":"Barnes","year":"2008","journal-title":"Pharm Stat"},{"key":"R20-28-20210112","doi-asserted-by":"crossref","first-page":"158","DOI":"10.7326\/0003-4819-153-3-201008030-00006","article-title":"Outcome reporting among drug trials registered in ClinicalTrials.gov.","volume":"153","author":"Bourgeois","year":"2010","journal-title":"Ann Intern Med"},{"key":"R25-28-20210112","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1371\/journal.pmed.0050230","article-title":"Bias, spin, and misreporting: time for full access to trial protocols and results.","volume":"5","author":"Chan","year":"2008","journal-title":"PLoS Med"},{"key":"R30-28-20210112","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1001\/jama.291.20.2457","article-title":"Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.","volume":"291","author":"Chan","year":"2004","journal-title":"JAMA"},{"key":"R35-28-20210112","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1503\/cmaj.1041086","article-title":"Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research.","volume":"171","author":"Chan","year":"2004","journal-title":"CMAJ"},{"key":"R40-28-20210112","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.293.23.jed50037","article-title":"Is this clinical trial fully registered? a statement from the International Committee of Medical Journal Editors.","volume":"293","author":"De Angelis","year":"2005","journal-title":"JAMA"},{"key":"R45-28-20210112","doi-asserted-by":"crossref","first-page":"e3081","DOI":"10.1371\/journal.pone.0003081","article-title":"Systematic review of the empirical evidence of study publication bias and outcome reporting bias.","volume":"3","author":"Dwan","year":"2008","journal-title":"PLoS ONE"},{"key":"R50-28-20210112","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/archinternmed.2010.406","article-title":"Testing for the presence of a positive-outcome bias in peer review.","volume":"170","author":"Emerson","year":"2010","journal-title":"Arch Intern Med"},{"key":"R55-28-20210112","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1371\/journal.pctr.0020018","article-title":"When and how can endpoints be changed after initiation of a randomized clinical trial?","volume":"2","author":"Evans","year":"2007","journal-title":"PLoS Clin Trial"},{"key":"R60-28-20210112","doi-asserted-by":"crossref","first-page":"400","DOI":"10.7326\/0003-4819-153-6-201009210-00008","article-title":"Clinical trials: discerning hype from substance.","volume":"153","author":"Fleming","year":"2010","journal-title":"Ann Intern Med"},{"key":"R70-28-20210112","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/1471-2474-12-278","article-title":"Comparison of published orthopaedic trauma trials following registration in ClinicalTrials.gov.","volume":"12","author":"Gandhi","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"R75-28-20210112","doi-asserted-by":"crossref","first-page":"e001186","DOI":"10.1136\/bmjopen-2012-001186","article-title":"How often do U.S.-based human subjects research studies register on time, and how often do they post their results? A statistical analysis of the ClinicalTrials.gov database.","volume":"2","author":"Gill","year":"2011","journal-title":"BMJ Open"},{"key":"R80-28-20210112","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1745-6215-12-249","article-title":"Why we need easy access to all data from all clinical trials and how to accomplish it.","volume":"12","author":"Gtzsche","year":"2011","journal-title":"Trials"},{"key":"R85-28-20210112","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.pain.2012.06.004","article-title":"A snapshot and scorecard for analgesic clinical trials for chronic pain: the RReACT database.","volume":"153","author":"Greene","year":"2012","journal-title":"PAIN"},{"key":"R90-28-20210112","doi-asserted-by":"crossref","first-page":"e25258","DOI":"10.1371\/journal.pone.0025258","article-title":"Completeness and changes in registered data and reporting bias of randomized controlled trials in ICMJE journals after trial registration policy.","volume":"6","author":"Huic","year":"2011","journal-title":"PLoS ONE"},{"key":"R95-28-20210112","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1371\/journal.pmed.0020124","article-title":"Why most published research findings are false.","volume":"2","author":"Ioannidis","year":"2005","journal-title":"PLoS Med"},{"key":"R100-28-20210112","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/art.34393","article-title":"Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis.","volume":"64","author":"Khan","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R105-28-20210112","doi-asserted-by":"crossref","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews.","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"key":"R110-28-20210112","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/jama.298.1.jed70037","article-title":"Clinical trial registration: looking back and moving ahead.","volume":"298","author":"Laine","year":"2007","journal-title":"JAMA"},{"key":"R115-28-20210112","first-page":"11","article-title":"A closer look at the baseline-observation-carried-forward (BOCF).","volume":"4","author":"Liu-Seifert","year":"2010","journal-title":"Patient Prefer Adher"},{"key":"R120-28-20210112","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.mayocp.2012.02.009","article-title":"Ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research: a joint journal and pharmaceutical industry perspective.","volume":"87","author":"Mansi","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"R125-28-20210112","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/jama.2009.1242","article-title":"Comparison of registered and published primary outcomes in randomized controlled trials.","volume":"302","author":"Mathieu","year":"2004","journal-title":"JAMA"},{"key":"R135-28-20210112","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses.","volume":"153","author":"Moore","year":"2012","journal-title":"PAIN"},{"key":"R140-28-20210112","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jpain.2010.01.001","article-title":"LOCF approach to handling missing data overestimates the pain score improvement of drop-outs.","volume":"11","author":"OConnor","year":"2010","journal-title":"J Pain"},{"key":"R150-28-20210112","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1371\/journal.pmed.0050217","article-title":"Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation.","volume":"5","author":"Rising","year":"2008","journal-title":"PLoS Med"},{"key":"R155-28-20210112","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pain.2009.09.026","article-title":"The case for publishing negative clinical trials.","volume":"146","author":"Rowbotham","year":"2009","journal-title":"PAIN"},{"key":"R160-28-20210112","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/10543400802609797","article-title":"MMRM vs LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets.","volume":"19","author":"Siddiqui","year":"2009","journal-title":"J Biopharm Stat"},{"key":"R165-28-20210112","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.arth.2011.11.005","article-title":"Comparison of arthroplasty trial publications after registration in ClinicalTrials.gov.","volume":"27","author":"Smith","year":"2012","journal-title":"J Arthroplasty"},{"key":"R170-28-20210112","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.pain.2008.06.025","article-title":"Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations.","volume":"139","author":"Turk","year":"2008","journal-title":"PAIN"},{"key":"R175-28-20210112","doi-asserted-by":"crossref","first-page":"e1001189","DOI":"10.1371\/journal.pmed.1001189","article-title":"Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the U.S. Food and Drug Administration database.","volume":"9","author":"Turner","year":"2012","journal-title":"PLoS Med"},{"key":"R180-28-20210112","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMsa065779","article-title":"Selective publication of antidepressant trials and its influence on apparent efficacy.","volume":"358","author":"Turner","year":"2008","journal-title":"N Engl J Med"},{"key":"R185-28-20210112","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMsa0906126","article-title":"Outcome reporting in industry-sponsored trials of Gabapentin for off-label use.","volume":"361","author":"Vedula","year":"2009","journal-title":"N Engl J Med"},{"key":"R190-28-20210112","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1745-6215-13-136","article-title":"Implementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin litigation.","volume":"13","author":"Vedula","year":"2012","journal-title":"Trials"},{"key":"R195-28-20210112","doi-asserted-by":"crossref","first-page":"e1001378","DOI":"10.1371\/journal.pmed.1001378","article-title":"Differences in reporting of analyses in internal company documents versus published trial reports: comparisons in industry-sponsored trials in off-label uses of Gabapentin.","volume":"10","author":"Vedula","year":"2013","journal-title":"PLoS Med"}],"container-title":["Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1016\/j.pain.2013.08.011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T04:47:38Z","timestamp":1623818858000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006396-201312000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pain.2013.08.011","relation":{},"ISSN":["0304-3959"],"issn-type":[{"value":"0304-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discrepancies between registered and published primary outcome specifications in analgesic trials: ACTTION systematic review and recommendations","name":"articletitle","label":"Article Title"},{"value":"PAIN\u00ae","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.pain.2013.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}